BENEFITING: Prize4Life, Inc.
ORGANIZER: Prize4Life, Inc.
EVENT DATE: Nov 03, 2013
I am beyond excited (and nervous) to have been chosen to join the Prize4Life team for the famous ING New York City Marathon this year! Running the NYC Marathon has been a goal of mine since my mom showed me the picture of her crossing the finish line with my grandpa many years ago. Over the many years of running competitively in high school and college, I have come to love the sport and it's community even more by accomplishing new goals, seeing new places, and making new friends.
What makes this year's event so special to me is that by representing the ALS organization, Prize4Life, I have the amazing opportunity to run in honor of my family member, Felix, who was diagnosed with ALS last year. Felix is a talented artist and teacher who has taught me a lot through dinner conversations about books, history, culture, and mutual interests. Despite his diagnosis, he continues to work on his artwork and has a photography show coming up in October. With his support and the support of his loving family, we are working together to increase awareness about ALS in our community and network of friends and family. I am honored to be a part of this process with them and to give back to a loving, welcoming family that has given me so much.
Please join me in contributing to a great cause, focused on promoting innovation and research through incentives and read more about the Prize4 Life organization and ALS below. Thank you for your support!
Prize4Life is a results-driven nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for Amyotrophic Lateral Sclerosis (ALS). Central to our work is a drive to generate new ideas, foster new research, and drive innovation that creates opportunities for breakthroughs in the pursuit of a cure for ALS. We are determined to eradicate ALS by catalyzing new ideas, eliminating barriers, and generating results.
Founded in 2006 by Avichai Kremer, who was diagnosed with ALS while a Harvard Business School student at age 29. We believe that solutions to some of the biggest challenges in ALS research will require out-of-the-box thinking, and that some of the most critical discoveries may come from unlikely places. To that end, our programs and initiatives focus on a prize-for-breakthrough model that provides both financial and other incentives for advancing progress on the path to a cure. For more information, visit www.prize4life.org.
ALS, more commonly known as Lou Gehrig’s disease, is a progressive, fatal, neurodegenerative disease that attacks motor neurons. When motor neurons die, the brain is no longer able to control muscle movement. Unable to function, muscles atrophy. Eventually, all muscles under voluntary control are affected and patients in time lose their ability to move, speak, swallow, or breathe on their own. During this process, the brain typically remains intact allowing the patient to anticipate and observe the loss of each function.
There are more than 600,000 people around the world suffering from ALS. The majority of whom will die within two to five years of diagnosis. At present, there is no cure or effective treatment for this indiscriminate, merciless illness.
To address this challenge, we have developed a series of prizes and ongoing programs that offer both financial incentives and material support for ALS research. Prize4Life’s programs already have yielded key results setting the stage for significant progress in the fight against ALS.